SCHEMBL24326460

SCHEMBL24326460

Cc1ccccc1-c1cc(Cl)nc(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.40
HSP90AB1 P08238 2/20 0.40
GPBAR1 Q8TDU6 6/20 0.37
ACACB O00763 2/20 0.36
ACACA Q13085 2/20 0.36
SDHB P21912 1/20 0.34
CYP1A2 P05177 2/20 0.34
CLK4 Q9HAZ1 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KMT2A Q03164 2/20 0.34
KDM4A O75164 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
PAX8 Q06710 1/20 0.33
CKS1B P61024 1/20 0.33
SKP1 P63208 1/20 0.33
SKP2 Q13309 1/20 0.33
SMYD2 Q9NRG4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24326710 0.88 CRHR1 (0.40) HSP90AA1GPBAR1ACACBACACASDHB
SCHEMBL22502015 0.87 HSP90AA1 (0.41) HSP90AA1HSP90AB1ACACBACACAPAX8
SCHEMBL24309477 0.85 HSP90AA1 (0.36) HSP90AA1HSP90AB1ACACBACACAKDM4A
SCHEMBL29566720 0.85 HSP90AA1 (0.36) HSP90AA1HSP90AB1ACACBACACAKDM4A
SCHEMBL24299011 0.82 HSP90AA1 (0.38) HSP90AA1HSP90AB1ACACBACACASMN1; SMN2
SCHEMBL29457817 0.82 HSP90AA1 (0.38) HSP90AA1HSP90AB1ACACBACACASMN1; SMN2
SCHEMBL30080281 0.82 ADORA2A (0.38) HSP90AA1HSP90AB1
SCHEMBL22304529 0.82 ADORA2A (0.38) HSP90AA1HSP90AB1
SCHEMBL22502018 0.81 HSP90AA1 (0.36) HSP90AA1HSP90AB1ACACBACACAPAX8
SCHEMBL22501987 0.81 HSP90AA1 (0.39) HSP90AA1HSP90AB1ACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018161-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2024-01-18 US disclosed
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018161-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CFTR, SCNN1G, SCNN1B HSP90AA1 1485/4885HSP90AB1 992/4885GPBAR1 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.